ArticleAdvances in therapy2025

Tabelecleucel in Post-transplant Epstein-Barr Virus-Associated Lymphoproliferative Disease: Patient and Oncologist Perspectives.

Antonio Perez-Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.